Shares of Aurobindo Pharma Ltd. gained as much as 2% on Thursday, February 26, after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, received final approval from the US Food and Drug Administration for Everolimus Tablets.The approval allows Eugia Unit I to...
anda approval
aurobindo pharma
eugia pharma specialities
european revenue growth
everolimus tablets
generic drugs
iqvia market data
kidney transplant
liver transplant
oncology drugs
organ transplantation
pharmaceutical manufacturing
pharmaceutical sales
research and development
usfoodanddrugadministration
